Erik L. Ridley and Philip Ward[email protected]Artificial IntelligenceRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesCTUnderstanding CT flow artifacts is key to better disease diagnosisUnderstanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.Molecular ImagingDual-tracer PET/CT shows promise in liver cancer patientsWomens ImagingStudies lacking for trans breast cancer screening trendsArtificial IntelligenceChatGPT performs poorly on ACR exam for residentsSponsor ContentIMV’s Oncology in Diagnostic Imaging Market Outlook Report